The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-((3-((4-(((R)-1-(3-amino-5-(trifluoromethyl)phenyl)ethyl)amino)-6-methoxy-2-methylquinazolin-7-yl)oxy)propyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione ID: ALA5277122
Max Phase: Preclinical
Molecular Formula: C35H34F3N7O6
Molecular Weight: 705.69
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc2c(N[C@H](C)c3cc(N)cc(C(F)(F)F)c3)nc(C)nc2cc1OCCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O
Standard InChI: InChI=1S/C35H34F3N7O6/c1-17(19-12-20(35(36,37)38)14-21(39)13-19)41-31-23-15-27(50-3)28(16-25(23)42-18(2)43-31)51-11-5-10-40-24-7-4-6-22-30(24)34(49)45(33(22)48)26-8-9-29(46)44-32(26)47/h4,6-7,12-17,26,40H,5,8-11,39H2,1-3H3,(H,41,42,43)(H,44,46,47)/t17-,26?/m1/s1
Standard InChI Key: LMBPERMEYQBSHS-SIHBAMTISA-N
Molfile:
RDKit 2D
51 56 0 0 0 0 0 0 0 0999 V2000
-5.0015 2.2671 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.2868 1.8548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2868 1.0304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5724 0.6183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8579 1.0304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8579 1.8548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5724 2.2671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1434 2.2671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1434 3.0915 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.4289 2.6793 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.4289 1.8548 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.5724 -0.2060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2868 -0.6182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8579 -0.6182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8579 -1.4427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5724 -1.8548 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.5724 -2.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2868 -3.0915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8579 -3.0915 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1434 -2.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1434 -1.8548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4289 -1.4427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7145 -1.8548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7145 -2.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -3.0915 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7145 -2.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4289 -3.0915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1434 -2.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8579 -3.0915 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5724 -2.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2868 -3.0915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0015 -2.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0015 -1.8548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2868 -1.4427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5724 -1.8548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9678 -1.3052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1709 -1.4976 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2976 -0.5632 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1220 -0.6457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6716 -0.0411 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8854 0.1510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0609 0.1510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6488 0.8655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0609 1.5801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8854 1.5801 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2976 0.8655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1220 0.8655 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6488 2.2946 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4289 -3.0915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.4427 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7145 -1.8548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
2 7 2 0
7 6 1 0
6 8 1 0
8 9 1 0
8 10 1 0
8 11 1 0
4 12 1 0
12 13 1 6
12 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
17 19 1 0
20 19 2 0
15 21 2 0
21 20 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
30 35 2 0
35 34 1 0
35 36 1 0
36 37 2 0
36 38 1 0
34 39 1 0
39 38 1 0
39 40 2 0
38 41 1 0
41 42 1 0
42 43 1 0
43 44 1 0
45 44 1 0
41 46 1 0
46 45 1 0
46 47 2 0
44 48 2 0
20 49 1 0
24 49 2 0
23 50 1 0
50 51 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 705.69Molecular Weight (Monoisotopic): 705.2523AlogP: 5.00#Rotatable Bonds: 11Polar Surface Area: 177.87Molecular Species: NEUTRALHBA: 11HBD: 4#RO5 Violations: 3HBA (Lipinski): 13HBD (Lipinski): 5#RO5 Violations (Lipinski): 3CX Acidic pKa: 11.59CX Basic pKa: 6.83CX LogP: 3.92CX LogD: 3.88Aromatic Rings: 4Heavy Atoms: 51QED Weighted: 0.09Np Likeness Score: -0.90
References 1. Bian Y, Alem D, Beato F, Hogenson TL, Yang X, Jiang K, Cai J, Ma WW, Fernandez-Zapico M, Tan AC, Lawrence NJ, Fleming JB, Yuan Y, Xie H.. (2022) Development of SOS1 Inhibitor-Based Degraders to Target KRAS -Mutant Colorectal Cancer., 65 (24.0): [PMID:36459180 ] [10.1021/acs.jmedchem.2c01300 ]